EUCTR2006-004427-11-SE进行中（未招募）不适用
Effects of Omega-3-Fatty Acids on Arterial Endothelial Function and Intima Media Thickness in Children with Insulin-Dependent Diabetes Mellitus
niv of Lund, Dept of Pediatrics0 个研究点目标入组 40 人开始时间: 2006年9月7日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children with type 1 diabetes mellitus aged 10-18 years and with a diabetes duration greater than 1 year
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Obesity. Acute infectious illness. Passive or active smoking. Hypertension. Family history of premature coronary heart disease (onset in first degree relative <55 years males and <60 years females)
研究者
相似试验
已完成
不适用
Effect of omega-3 fatty acid on endothelial dysfunction induced by postprandial hypelipidemiaHealthy subjectsJPRN-UMIN000012556Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences10
招募中
2 期
The effect of omega-3 supplementation on endothelial function, vascular structure and metabolic parameters in adolescents with type 1 diabetesType 1 diabetes mellitusIRCT20210419051010N1Iran University of Medical Sciences30
已完成
不适用
Effect of Omega-3 supplementation on endothelial function & quality of life in hemodialysis patientsEnd Stage Renal Disease.End Stage Renal DiseaseIRCT201309242417N13Vice Chancellor for Research, Isfahan University of Medical Sciences60
已完成
不适用
Fish Oils in LupusSystemic Lupus Erythematosus (SLE)Musculoskeletal DiseasesErythematosusISRCTN66445141Queen's University of Belfast (UK)60
进行中（未招募）
1 期
Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences - Fish oils in LupusSystemic Lupus ErythematosusEUCTR2004-004404-21-GBGreenPark Healthcare Trust60